Hassan Dorani

INFLUENCE OF ERYTHROMYCIN ON THE PHARMACOKINETICS OF XIMELAGATRAN MAY INVOLVE INHIBITION OF P-GLYCOPROTEIN-MEDIATED EXCRETION

Ulf G. Eriksson, Hassan Dorani, Johan Karlsson et al. · Drug Metabolism and Disposition · 2006 · 43 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

No Pharmacokinetic or Pharmacodynamic Interaction Between Atorvastatin and the Oral Direct Thrombin Inhibitor Ximelagatran

Troy C. Sarich, Kajs‐Marie Schützer, Hassan Dorani et al. · The Journal of Clinical Pharmacology · 2004 · 23 citations

Medicine, Pharmacokinetics, Pharmacology +13

Pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor ximelagatran co-administered with different classes of antibiotics in healthy volunteers

Hassan Dorani, Kajs-Marie Schützer, Troy C. Sarich et al. · European Journal of Clinical Pharmacology · 2007 · 15 citations

Medicine, Pharmacokinetics, Pharmacology +15

The glucokinase activator AZD6370 decreases fasting and postprandial glucose in type 2 diabetes mellitus patients with effects influenced by dosing regimen and food

Hans Ericsson, Folke Sjöberg, Maria Heijer et al. · Diabetes Research and Clinical Practice · 2012 · 13 citations

Medicine, Biochemistry, Endocrinology +16